Vasco Knight@LINC 2024 | Impact of Different Pre-Dilation Modalities on DCB Treatment for Femoropopliteal Occlusive Disease: 12-Month Results from the CIVILIAN Study
时间: 2025-03-31
作者: 小编:
阅读量: 51
关键词:

Speaker: Weihao Shi, MD

Hospital: Huashan Hospital, Fudan University


Abstract


The CIVILIAN study prospectively compared Chocolate balloon (CLP), conventional balloon (CP), and sequential balloon pre-dilation (SEP) in 435 patients with femoropopliteal occlusive disease treated by DCB. Results showed CLP significantly reduced bailout stenting rates (18.1% vs. 30.1%, p=0.011) and simplified procedures compared to SEP.


Introduction


Optimal vessel preparation is critical for DCB efficacy. This registry analyzed CLP’s ability to minimize dissection and stent dependency while maintaining procedural simplicity.


a24a5f0435dc3569eb986c2bee91846.jpg


160ec3760472c92436f08f7f3f3f918.jpg


Case Studies


Bailout Stenting


CLP: 18.1% vs. CP: 30.1% (p=0.011).


Maximal Pre-dilation Balloon Diameter


CLP: 4.74±0.52 mm vs. CP: 4.36±0.64 mm (p<0.001).<>


434ac0385973067d43a29e92eabfa0b.jpg


12-Month MAE


13-CLP: 7.8% vs. SEP: 9.7% (p=0.436).


4375d6270bd6e50f0613e0ada7e4352.jpg


4991475b5bcc56604b4e6c82b643c4a.jpg


Conclusion


1.CLP reduces bailout stenting and offers procedural simplicity.


2.SEP provides larger lumens but requires complex techniques.


3.Long-term follow-up will clarify DCB sizing benefits.


d53f668eee6e3e19641266acbf9dccd.jpg